Biodesix, Inc. (BDSX)
8.10
-0.20
(-2.41%)
USD |
NASDAQ |
Nov 20, 10:46
Biodesix Cash from Operations (Quarterly) : -7.203M for Sept. 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -7.203M |
| June 30, 2026 | -1.601M |
| March 31, 2026 | -10.17M |
| December 31, 2025 | 0.748M |
| September 30, 2025 | -8.879M |
| June 30, 2025 | -6.557M |
| March 31, 2025 | -8.613M |
| December 31, 2024 | -4.102M |
| September 30, 2024 | -10.67M |
| June 30, 2024 | -18.59M |
| March 31, 2024 | -15.33M |
| December 31, 2023 | -11.45M |
| September 30, 2023 | -3.839M |
| June 30, 2023 | 0.906M |
| Date | Value |
|---|---|
| March 31, 2023 | -8.487M |
| December 31, 2022 | -11.95M |
| September 30, 2022 | -10.33M |
| June 30, 2022 | -9.594M |
| March 31, 2022 | -13.10M |
| December 31, 2021 | -10.20M |
| September 30, 2021 | -7.79M |
| June 30, 2021 | 1.09M |
| March 31, 2021 | -11.33M |
| December 31, 2020 | -8.756M |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | -4.537M |
| December 31, 2019 | -5.729M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| BillionToOne, Inc. | 12.55M |
| Quest Diagnostics, Inc. | 611.00M |
| Labcorp Holdings, Inc. | 563.80M |
| OPKO Health, Inc. | -36.32M |
| Psychemedics Corp. | -- |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.60M |
| Cash from Financing (Quarterly) | 6.216M |
| Free Cash Flow | -19.33M |
| Free Cash Flow Per Share (Quarterly) | -0.732 |
| Free Cash Flow to Equity (Quarterly) | -8.447M |
| Free Cash Flow to Firm (Quarterly) | -5.801M |
| Free Cash Flow Yield | -21.58% |